RNL Life Scicence Information

RNL Bio RNL Bio is a Korea-based public company that is dedicated to the commercialization of stem cell-based therapeutics. RNL Bio is a pioneer in the use of adipose and other tissue-derived stem cells for the treatment of indications of unmet clinical need. RNL Bio is licensing to us rights and intellectual property to commercialize several applications of their harvest and therapy applications of stem cells. RNL Bio is a leader in the harvest and growth of stem cells derived from Adipose tissue. Adipose is body fat composed of lipoblasts. The main role of lipoblasts is to store energy in the form of fat, although it also cushions and insulates the body. RNL Bio’s research has been guided by its proprietary understanding of the isolation, expansion and administration of stem cells. Through this innovation, a large number of adult stem cells can be efficiently and rapidly obtained for therapeutic use.